Ekso Bionics Holdings, Inc.
EKSO
$3.49
$0.010.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -19.32% | -2.06% | -1.94% | 4.12% | 15.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.32% | -2.06% | -1.94% | 4.12% | 15.63% |
| Cost of Revenue | -18.80% | -7.94% | -8.54% | -0.92% | 8.16% |
| Gross Profit | -19.81% | 3.72% | 4.76% | 9.28% | 23.56% |
| SG&A Expenses | -2.50% | -9.73% | -15.37% | -16.56% | -16.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.20% | -12.02% | -14.99% | -11.25% | -7.37% |
| Operating Income | -1.11% | 24.83% | 30.78% | 27.46% | 28.84% |
| Income Before Tax | 10.78% | 24.20% | 25.45% | 26.59% | 22.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 10.78% | 24.20% | 25.45% | 26.59% | 22.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.78% | 24.20% | 25.45% | 26.59% | 22.84% |
| EBIT | -1.11% | 24.83% | 30.78% | 27.46% | 28.84% |
| EBITDA | -2.25% | 27.36% | 34.01% | 31.14% | 33.71% |
| EPS Basic | 44.73% | 49.73% | 48.27% | 41.66% | 34.68% |
| Normalized Basic EPS | 45.19% | 50.14% | 48.84% | 42.22% | 35.20% |
| EPS Diluted | 44.99% | 49.93% | 48.46% | 41.32% | 34.37% |
| Normalized Diluted EPS | 45.19% | 50.14% | 48.84% | 42.22% | 35.20% |
| Average Basic Shares Outstanding | 60.59% | 48.67% | 45.34% | 29.98% | 20.69% |
| Average Diluted Shares Outstanding | 60.59% | 48.67% | 45.34% | 29.98% | 20.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |